Risk group accurately predicts outcome in primary extremity non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) in patients <30 years of age: Findings from Children’s Oncology Group study ARST0332.

10546Background: Data are limited on primary extremity NRSTS in pediatric patients. Methods: This ARST0332 subset analysis evaluated the clinical features and outcomes of extremity (including shoul...